Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Safety Scientist to provide safety science and pharmacovigilance support to all products across the RevMed portfolio, including clinical studies, review of clinical trial protocols, and authoring of DSURs.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Alexion Pharmaceuticals, Inc.